87 related articles for article (PubMed ID: 26914377)
1. Prognostic importance of CD56 expression in intermediate risk acute myeloid leukaemia.
Coelho-Silva JL; Carvalho LE; Oliveira MM; Franca-Neto PL; Andrade AT; Lima AS; Bezerra MF; Lima MM; Neves MA; Fonseca JM; Barros-Correia MC; Machado CG; Bezerra MA; Matos DM; Lucena-Araujo AR
Br J Haematol; 2017 Feb; 176(3):498-501. PubMed ID: 26914377
[No Abstract] [Full Text] [Related]
2. Prognostic significance of CD56 antigen expression in patients with acute myeloid leukemia.
Djunic I; Virijevic M; Djurasinovic V; Novkovic A; Colovic N; Kraguljac-Kurtovic N; Vidovic A; Suvajdzic-Vukovic N; Tomin D
Med Oncol; 2012 Sep; 29(3):2077-82. PubMed ID: 22081445
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of CD56 expression in patients with acute myeloid leukemia.
Lee JJ; Chung IJ; Yang DH; Cho SH; Cho D; Ryang DW; Kim HJ
Leuk Lymphoma; 2002 Sep; 43(9):1897-9. PubMed ID: 12685854
[No Abstract] [Full Text] [Related]
4. High expression of CD56 may be associated with favorable overall survival in intermediate-risk acute myeloid leukemia.
Chen C; Chio CL; Zeng H; Li Y
Hematology; 2021 Dec; 26(1):210-214. PubMed ID: 33594945
[TBL] [Abstract][Full Text] [Related]
5. Correlation of CD11b and CD56 expression in adult acute myeloid leukemia with cytogenetic risk groups and prognosis.
Juncà J; Garcia-Caro M; Granada I; Rodríguez-Hernández I; Torrent A; Morgades M; Ribera JM; Millá F; Feliu E
Ann Hematol; 2014 Sep; 93(9):1483-9. PubMed ID: 24782118
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of CD200 and CD56 Expression in Patients with Acute Myeloid Leukemia.
Aref S; Abousamra N; El-Helaly E; Mabed M
Asian Pac J Cancer Prev; 2020 Mar; 21(3):743-748. PubMed ID: 32212802
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors.
Damiani D; Tiribelli M; Raspadori D; Sirianni S; Meneghel A; Cavalllin M; Michelutti A; Toffoletti E; Geromin A; Simeone E; Bocchia M; Fanin R
Oncotarget; 2015 Oct; 6(30):30212-21. PubMed ID: 26338961
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and prognosis of acute myeloid leukemia associated with DNA-methylation regulatory gene mutations.
Ryotokuji T; Yamaguchi H; Ueki T; Usuki K; Kurosawa S; Kobayashi Y; Kawata E; Tajika K; Gomi S; Kanda J; Kobayashi A; Omori I; Marumo A; Fujiwara Y; Yui S; Terada K; Fukunaga K; Hirakawa T; Arai K; Kitano T; Kosaka F; Tamai H; Nakayama K; Wakita S; Fukuda T; Inokuchi K
Haematologica; 2016 Sep; 101(9):1074-81. PubMed ID: 27247325
[TBL] [Abstract][Full Text] [Related]
9. Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation.
Yang DH; Lee JJ; Mun YC; Shin HJ; Kim YK; Cho SH; Chung IJ; Seong CM; Kim HJ
Am J Hematol; 2007 Jan; 82(1):1-5. PubMed ID: 16986129
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of immunophenotyping and gene mutations in elderly patients with acute myeloid leukemia with normal karyotype.
Dang H; Jiang A; Kamel-Reid S; Brandwein J; Chang H
Hum Pathol; 2013 Jan; 44(1):55-61. PubMed ID: 22939316
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of CD56 in patients with acute myeloid leukemia: a meta-analysis.
Xu S; Li X; Zhang J; Chen J
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1859-70. PubMed ID: 25924702
[TBL] [Abstract][Full Text] [Related]
12. CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21).
Iriyama N; Hatta Y; Takeuchi J; Ogawa Y; Ohtake S; Sakura T; Mitani K; Ishida F; Takahashi M; Maeda T; Izumi T; Sakamaki H; Miyawaki S; Honda S; Miyazaki Y; Taki T; Taniwaki M; Naoe T
Leuk Res; 2013 Sep; 37(9):1021-6. PubMed ID: 23810283
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukaemia: expression of MYC protein and its association with cytogenetic risk profile and overall survival.
Mughal MK; Akhter A; Street L; Pournazari P; Shabani-Rad MT; Mansoor A
Hematol Oncol; 2017 Sep; 35(3):350-356. PubMed ID: 26856970
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
[TBL] [Abstract][Full Text] [Related]
15. Clinical and prognostic implications of Roundabout 4 (robo4) in adult patients with acute myeloid leukemia.
Chen YK; Hou HA; Tang JL; Jhuang JY; Lai YJ; Lee MC; Kuo YY; Chou WC; Liu CY; Lin CW; Chuang SS; Chen CY; Tseng MH; Huang CF; Chiang YC; Lee FY; Liu MC; Liu CW; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Tien HF
PLoS One; 2015; 10(3):e0119831. PubMed ID: 25794001
[TBL] [Abstract][Full Text] [Related]
16. BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients.
Damiani D; Tiribelli M; Franzoni A; Michelutti A; Fabbro D; Cavallin M; Toffoletti E; Simeone E; Fanin R; Damante G
Am J Hematol; 2013 Oct; 88(10):848-52. PubMed ID: 23760853
[TBL] [Abstract][Full Text] [Related]
17. The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia.
Díaz-Beyá M; Brunet S; Nomdedéu J; Cordeiro A; Tormo M; Escoda L; Ribera JM; Arnan M; Heras I; Gallardo D; Bargay J; Queipo de Llano MP; Salamero O; Martí JM; Sampol A; Pedro C; Hoyos M; Pratcorona M; Castellano JJ; Nomdedeu M; Risueño RM; Sierra J; Monzó M; Navarro A; Esteve J
Blood Cancer J; 2015 Oct; 5(10):e352. PubMed ID: 26430723
[TBL] [Abstract][Full Text] [Related]
18. [Expression of CD56 in acute leukemia and its clinical significance].
Zhang Y; Tang YM; Yang SL; Shen HQ; Qian BQ; Song H; Shi SW; Xu WQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):187-90. PubMed ID: 12513782
[TBL] [Abstract][Full Text] [Related]
19. Frequency and prognostic impact of FLT3/ITD mutation in patients with acute myeloid leukaemia.
Govedarovic N; Marjanovic G
J BUON; 2011; 16(1):108-11. PubMed ID: 21674859
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of acute myeloid leukemia -- a single center experience (2007-2013)].
Selmeczi A; Udvardy M; Illés A; Telek B; Kiss A; Batár P; Reményi G; Szász R; Ujj Z; Márton A; Ujfalusi A; Hevessy Z; Pinczés L; Bedekovics J; Rejtő L
Orv Hetil; 2014 Apr; 155(17):653-8. PubMed ID: 24755447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
